CGEO Investor presentation

Page 1

GEORGIA CAPITAL INVESTOR PRESENTATION 4 AUGUST 2026

Page 2

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY 03 2Q26 & 1H26 PERFORMANCE OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES CONTENTS 2

Page 3

44.5% UK 21.2% South Africa 5.9% Switzerland 3.3% Norway 2.9% Spain 2.5% Germany 2.0% Other 17.8% 34.0 MILLION SHARES ISSUED Rank Shareholder name Ownership 1 Wellington Management Company 8.23% 2 Gemsstock 6.12% 3 Allan Gray Proprietary 5.66% 4 Eaton Vance Management 4.52% 5 Lazard Asset Management 4.03% 6 Dimensional Fund Advisors 3.63% 7 Firebird Management 3.35% 8 Halcyon Portfolio Management 2.66% 9 BlackRock 1.79% 10 JP Morgan International Bank 1.63% Total 41.62% GEORGIA CAPITAL (GCAP) SHAREHOLDERS AT 30-JUN-26 Georgia Capital PLC | 1. USA also includes Cayman Islands. 2. UK also includes Channel Islands. 3 GCAP SHAREHOLDERS ALLOCATION BY GEOGRAPHY GCAP TOP 10 SHAREHOLDERS 2 1USA

Page 4

KEY FIGURES AT A GLANCE Georgia Capital PLC | 1. Values are converted in US$ via 30-Jun-26 official exchange rate (2.6453), published by the National Bank of Georgia (NBG). 4 NAV HIGHLIGHTS AT 30-JUN-261 5,413 GEL million 384 GEL million Portfolio value Net cash 5,794 GEL million 175.12 GEL NAV NAV per share PORTFOLIO VALUE BREAKDOWN AT 30-JUN-26 STARTING FROM 2024, PLATFORM COSTS ARE TARGETED AT MAXIMUM 0.75% OF NAV US$ 2,046 million US$ 145 million US$ 2,190 million US$ 66.20 47% 53% Listed Private

Page 5

OUR PORTFOLIO OVERVIEW AS AT 30-JUN-26 5 LISTED PORTFOLIO PRIVATE PORTFOLIO VALUE: GEL 2,537 MILLION 46.9% OF THE TOTAL PORTFOLIO VALUE: GEL 2,876 MILLION 53.1% OF THE TOTAL PORTFOLIO LION FINANCE GROUP VALUE: GEL 2,537 M 46.9% OF THE TOTAL PORTFOLIO RETAIL (PHARMACY) LARGE PORTFOLIO COMPANIES HEALTHCARE SERVICES INSURANCE (P&C AND MEDICAL) EMERGING AND OTHER BUSINESSES 1) Renewable Energy 2) Education 3) Auto Service 4) Wine 5) Hospitality 6) Beer and distribution VALUE: GEL 1,035 M 19.1% OF THE TOTAL PORTFOLIO VALUE: GEL 688 M 12.7% OF THE TOTAL PORTFOLIO VALUE: GEL 611 M 11.3% OF THE TOTAL PORTFOLIO VALUE: GEL 542 M 10.0% OF THE TOTAL PORTFOLIO 5Georgia Capital PLC | 1. Following the disposal of an 80% stake in the beer and distribution business, the remaining 20% ownership retained by GCAP continues to be included in the portfolio value under emerging and other businesses. 1

Page 6

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY 03 2Q26 & 1H26 PERFORMANCE OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES CONTENTS 6 6

Page 7

7 OUR STRATEGY OUR ROBUST CAPITAL MANAGEMENT FRAMEWORK INVESTING IN CAPITAL- LIGHT OPPORTUNITIES ONLY ESG AT THE CORE OF OUR STRATEGY 0201 03 ESG

Page 8

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY ▪ Investing in capital-light opportunities only ▪ Our capital management framework ▪ ESG at the core of our strategy ▪ Our strategic priorities 03 2Q26 & 1H26 PERFORMANCE OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES CONTENTS 8

Page 9

THE CAPITAL-LIGHT INVESTMENT STRATEGY 9 STRONG VALUE CREATION POTENTIAL WITHOUT SIGNIFICANT CAPITAL COMMITMENTS STRONG TRACK RECORD IN TAPPING BIG OPPORTUNITIES WITH SMALL INVESTMENTS BY CONSOLIDATING FRAGMENTED INDUSTRIES, ESPECIALLY IN SERVICE-ORIENTED SECTORS OUR BREAD AND BUTTER GCAP INVESTS IN GEORGIA IN SECTORS NOT REQUIRING INTENSIVE CAPITAL COMMITMENTS Manage third-party money and/or establish partnerships in capital heavy industries

Page 10

10 INVEST IN CAPITAL-LIGHT LARGE OPPORTUNITIES IN GEORGIA GROW BUSINESSES TO EQUITY VALUE OF GEL 300+ MILLION MONETISE OUR INVESTMENT STRATEGY GCAP INVESTS IN CAPITAL-LIGHT, LARGE OPPORTUNITIES, WHICH HAVE A POTENTIAL TO BECOME GEL 300+ MILLION IN EQUITY VALUE OVER 3-5 YEARS Invest Our key strategic principle is to develop or buy capital-light businesses at affordable prices. Grow GCAP helps the portfolio companies institutionalise their management, enhance their governance and grow them into mature businesses that can further develop largely on their own, either with continued oversight or independently. Monetise As investments mature, GCAP intends to realise proceeds through exits at attractive prices. THE CYCLE OF GCAP’S STRATEGY

Page 11

OUR INVESTMENT STRATEGY (CONT’D) 11 KEY INVESTMENT METRICS AT GCAP LEVEL MOIC IRR IRR & MOIC1 IS THE KEY DRIVER FOR GCAP TO INVEST IN NEW OPPORTUNITIES Georgia Capital PLC | 1. Multiple of Capital Invested (MOIC). ROIC IS AT THE CORE OF OUR DECISION MAKING WHEN OUR PORTFOLIO COMPANIES ARE INVESTING OR DIVESTING ASSETS / BUSINESSES KEY METRIC FOR REINVESTMENT DECISION MAKING AT PORTFOLIO COMPANIES’ LEVEL ROIC • ROIC should exceed WACC for all new investments • Portfolio companies to continue divestment of low ROIC and/or non-core assets & businesses to enhance ROIC

Page 12

Page 13

13 NET CAPITAL COMMITMENT (NCC) OVERVIEW NCC RATIO DOWN BY 6.8 PPTS TO ITS RECORD-LOW LEVEL AS OF 30-JUN-26 The improvement was supported by: ✓ robust cash generation ✓ continued portfolio value growth ✓ strengthened risk profile of the Group -5.7% -0.9% 0.3% -0.8% 0.3% NCC 31-Mar-26 Increase in net cash Decrease in announced buybacks Change in planned investments Change in contingency buffer Increase in portfolio value NCC 30-Jun-26 2.3% -6.8 ppts DRIVERS OF Q-O-Q CHANGE IN NCC 3.9% 3.9% OVER THE CYCLE TARGET OF 10% -2.9% 3.6% -2.9% GCAP’S EXCELLENT FINANCIAL POSITION AND PRUDENT FINANCIAL POLICY WAS RECOGNISED BY S&P GLOBAL RATINGS, WHICH UPGRADED GCAP’S CREDIT RATING TO BB (STABLE) FROM BB- (POSITIVE), ALIGNING GCAP WITH THE SOVEREIGN CREDIT RATING OF GEORGIA

Page 14

360-DEGREE FRAMEWORK 14 WE PERFORM 360-DEGREE ANALYSIS EACH TIME WE MAKE A CAPITAL ALLOCATION DECISION AND COMPARE: • Investment opportunity vs. buyback opportunity • Sale opportunity vs. buyback opportunity 360o ANALYSIS Sale opportunity Buybackopportunity Investmentopportunity NCC RATIO NAVIGATION TOOLGCAP SHARE PRICE IS AT THE CORE OF OUR INVESTMENT DECISION MAKING 10% 40% MEANINGFUL BUYBACKS & INVESTMENTS TACTICAL BUYBACKS & INVESTMENTS CASH PRESERVATION STRATEGY CAPITAL ALLOCATIONS

Page 15

42.5% 39.8% 31.9% 21.1% 15.6% 12.8% 2.3% -2.9% 10.0% 345.7 365.9 385.8 250.1 213.6 171.3 42.8 (59.3) 31-Dec-19 31-Dec-20 31-Dec-21 31-Dec-22 31-Dec-23 31-Dec-24 31-Dec-25 30-Jun-26 Target NCC ratio Net Capital Commitment (US$ million) 15 NCC RATIO DEVELOPMENT OVERVIEW Over the cycle Target NCC AND NCC RATIO DEVELOPMENT OVERVIEW1 OVER THE CYCLE TARGET NCC REPRESENTS AN AGGREGATED VIEW OF ALL CONFIRMED, AGREED AND EXPECTED CAPITAL OUTFLOWS AT THE GCAP HOLDCO LEVEL Georgia Capital PLC | 1. Reflects the retrospective conversion of the loans issued to our other businesses into equity. -5.2 ppts

Page 16

16 LEVERAGE OVERVIEW OF OUR PRIVATE BUSINESSES GCAP’S DELEVERAGING STRATEGY HAS PUT THE PORTFOLIO IN ITS STRONGEST BALANCE-SHEET POSITION TO DATE Georgia Capital PLC | General note: Figures for retail (pharmacy) and healthcare services businesses are given excluding IFRS 16 effects. Net debt includes the application of the minority buyout agreement in the retail (pharmacy) business and assumes the reclassification of the loans issued to our real estate business as quasi-equity facilities throughout 2019 - 2021. All figures are given excluding beer and distribution business. For renewable energy business, figures are calculated in US$ terms. 1. LTM EBITDA excludes the gain of GEL 2.9 million from the sale of one of the polyclinics buildings in 3Q23. 2. Incorporates disposal of Batumi Hospital. 3. Medical insurance is given including Ardi. 4. Excludes the housing development business, which was divested in June 2026. GEL MILLION 195 220 249 222 219 221 214 240 281 309 333 351 353 958 934 852 877 758 748 816 908 873 853 894 881 747 4.9x 4.3x 3.4x 3.9x 3.5x 3.4x 3.8x 3.8x 3.1x 2.8x 2.7x 2.5x 2.1x Dec-19 Dec-20 Dec-21 Jun-22 Dec-22 Jun-23 Dec-23 Jun-24 Dec-24 Jun-25 Dec-25 Mar-26 Jun-26 Total LTM EBITDA Total Net debt Total Net debt/EBITDA 1,2,3 3 3 3 3 3, 41,2 ➢ NET DEBT/EBITDA DECLINED FROM 4.9x AS OF DEC-19 TO ITS LOWEST LEVEL OF 2.1x AS OF JUN-26 ➢ TOTAL NET DEBT DECREASED BY 22.0% AS OF JUN-26 COMPARED TO ITS LEVEL AS OF DEC-19 ➢ LTM EBITDA INCREASED BY 80.4% AS OF JUN-26 COMPARED TO DEC-19

Page 17

17 LEVERAGE OVERVIEW OF OUR LARGE BUSINESSES 0.0x 0.5x 0.4x 0.2x 1.0x 31-Dec-23 31-Dec-24 31-Dec-25 30-Jun-26 Allowed 2.2x 1.9x 1.3x 0.8x 2.0x 31-Dec-23 31-Dec-24 31-Dec-25 30-Jun-26 Allowed 5.0x 4.3x 3.7x 3.5x 3.0x 31-Dec-23 31-Dec-24 31-Dec-25 30-Jun-26 Allowed HEALTHCARE SERVICES ALLOWED LEVERAGE RETAIL (PHARMACY) INSURANCE BELOW LIMIT ALLOWED LEVERAGE ALLOWED LEVERAGE ABOVE LIMIT BELOW LIMIT NO LEVERAGE NET DEBT TO EBITDA DEVELOPMENT OVERVIEW

Page 18

Page 19

CORE STRATEGY ENABLERS 19 THREE FUNDAMENTAL ENABLERS THREE FUNDAMENTAL ENABLERS: 01 Superior corporate governance 02 Access to management 03 Access to capital ACCESS TO CAPITALACCESS TO MANAGEMENT STRONG CORPORATE GOVERNANCE

Page 20

Female 78% Male 22% ENVIRONMENTAL, SOCIAL AND GOVERNANCE PRINCIPLES LIE AT THE HEART OF OUR BUSINESS 20 OUR PORTFOLIO IS CONCENTRATED ACROSS STRUCTURALLY IMPORTANT INDUSTRIES IN GEORGIA, CONNECTING US TO THE COUNTRY’S SUSTAINABLE DEVELOPMENT OVER 20,200 EMPLOYEES AT THE GROUP LEVEL WE INVEST IN INDUSTRIES WHICH HAVE POSITIVE IMPACT ON PEOPLE AND PLANET OUR HEALTHCARE SERVICES BUSINESS STRENGTHENS GEORGIA’S HEALTHCARE SYSTEM BY EXPANDING ACCESS TO QUALITY MEDICAL SERVICES THROUGH OUR GREEN INITIATIVES, THE RENEWABLE ENERGY BUSINESS CONTRIBUTES TO CLIMATE CHANGE MITIGATION BY PROMOTING CLEAN POWER GENERATION OUR EDUCATION BUSINESS EMPOWERS FUTURE GENERATIONS BY ENHANCING ACCESS TO QUALITY EDUCATION OUR AUTO SERVICE BUSINESS CONTRIBUTES TO REDUCING GREENHOUSE GAS EMISSIONS AND MINIMISING ROAD TRAFFIC ACCIDENTS IN GEORGIA LARGEST EMPLOYER IN THE GEORGIAN PRIVATE SECTOR OUR PHARMACY BUSINESS SUPPORTS COMMUNITY HEALTH BY ENSURING ACCESS TO HIGH-QUALITY MEDICINES AND PROMOTING HEALTH AWARENESS

Page 21

ESG AT THE CORE OF OUR STRATEGY 21 RECENT KEY ESG DEVELOPMENTS STRENGTHENED ESG RISK ASSESSMENT AND MANAGEMENT PROCESSES COMMITTED TO THE NET-ZERO INITIATIVE 03 0402 ➢ IN 2022, GEORGIA CAPITAL COMMITTED TO THE NET-ZERO 2050 INITIATIVE. ➢ FOR THE FIRST TIME IN GEORGIA, GCAP SUCCESSFULLY OBTAINED THIRD-PARTY ASSURANCE ON ITS GREENHOUSE GAS EMISSIONS. ➢ ADB AWARDED GEORGIA CAPITAL WITH AN IMPACT AWARD IN APRIL 2024. ➢ IN 2024, GEORGIA CAPITAL STRENGTHENED ITS ESG RISK ASSESSMENT AND MANAGEMENT FRAMEWORK. ➢ THE COMPANY ALSO ESTABLISHED A FORMAL STAKEHOLDER ENGAGEMENT PLAN. 01 ISSUED FIRST EVER SUSTAINABILITY-LINKED BONDS IN THE REGION ➢ IN 2023, GEORGIA CAPITAL ISSUED US$ 150 MILLION SUSTAINABILITY-LINKED BONDS (“SLB”) AND ESTABLISHED A SLB FRAMEWORK, UNDER WHICH GCAP INTENDS TO DECREASE ITS GHG EMISSIONS BY 20% BY 2027. ➢ IN JUNE 2026, GCAP EXERCISED ITS CALL OPTION TO EARLY REDEEM THE SLB IN FULL. DESPITE THE REDEMPTION, GCAP REMAINS FULLY COMMITTED TO DELIVERING ON ITS SUSTAINABILITY OBJECTIVES. DELIVERED ON THE STRATEGIC PRIORITY ➢ GCAP DELIVERED ON ITS STRATEGIC PRIORITY OF SETTING MEASURABLE ESG TARGETS AND ESTABLISHED THE ESG ACTION PLAN. ➢ GCAP ANALYSED THE RELEVANT ESG FRAMEWORKS AND GUIDELINES AND DETERMINED THE MATERIALITY OF ESG MATTERS ACROSS THE BUSINESS OPERATIONS.

Page 22

INCREASED FOCUS ON IMPACT INVESTING 22 COMMITTING TO UN’S PRINCIPLES AND MAPPING OUR BUSINESSES TO THEIR SUSTAINABLE DEVELOPMENT GOALS (“SDGS”) Business Direct SDG Impact Supportive / Indirect SDG Impact GCAP HoldCo 8, 10, 13 5 Retail (pharmacy) 3, 8, 12 5, 11 Healthcare services 3, 8, 9, 12 5, 11 Insurance 3, 8, 9 1, 10 Renewable energy 7, 9, 13 8, 11 Education 4 3, 11, 16 Auto services 9, 11,13 15 Banking 1, 8, 11 5

Page 23

Page 24

24 OUR STRATEGIC PRIORITIES ESG DELEVERAGING GCAP HOLDCO BY BRINGING DOWN AND MAINTAINING THE NCC RATIO BELOW 10% REDUCE AND MAINTAIN PORTFOLIO COMPANIES’ LEVERAGE TO RESPECTIVE TARGETED LEVELS ACHIEVE ESG TARGETS AT BOTH GCAP HOLDCO AND PORTFOLIO COMPANY LEVELS CONTINUED PROGRESS ON THE DIVESTMENT OF EMERGING AND OTHER PORTFOLIO COMPANIES

Page 25

OUR LONG-TERM ASPIRATION 2525 ACHIEVEMENT OF OUR STRATEGIC PRIORITIES WILL ENABLE GCAP TO GRADUALLY TRANSFORM INTO A SUSTAINABLE PERMANENT CAPITAL VEHICLE (PCV) Significantly reduced leverage at the GCAP HoldCo level Capacity to redeploy our existing capital without the need for new equity share issuance/raise Consistent NAV per share growth on the back of resilient, capital-light investments Opportunity to return a significant portion of GCAP’s cash inflows to our shareholders

Page 26

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY 03 2Q26 & 1H26 PERFORMANCE OVERVIEW ▪ GCAP RESULTS OVERVIEW ▪ AGGREGATED PORTFOLIO RESULTS OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES CONTENTS 26

Page 27

6 5 3 2 1 NAV per share increased by 13.1% q-o-q to a record high of GEL 175.12 (up 15.6% q-o-q to GBP 50.10), driven by strong operating performances across our large private portfolio companies and continued growth in Lion Finance Group PLC’s share price 4 27 KEY DEVELOPMENTS Disposal of our housing development business, in line with our capital-light investment strategy, while also strengthening GCAP’s risk profile. Total net debt of the emerging and other businesses (ex. renewable energy) declined c.49% (by c.US$ 39 million), with net debt-to-EBITDA improving from 3.8x to 2.0x Accelerated revenue growth across our large private portfolio companies, with aggregate revenues up 19.1% y-o-y in 2Q26, compared to 14.3% in 2Q25, extending the delivery of double-digit growth to eight consecutive quarters NCC ratio improved by 6.8 ppts q-o-q to a record-low -2.9% as of 30 June 2026, marking our strongest capital position to date, driven by robust cash generation and continued portfolio value creation S&P Global Ratings upgraded GCAP’s corporate credit rating from BB- (Positive) to BB (Stable), bringing the rating fully in line with Georgia’s sovereign credit rating Completion of the GEL 700 million capital return programme significantly ahead of schedule through the early redemption of local sustainability-linked bonds and the extension of the existing share buyback programme 7 Commencement of a new GEL 1 billion capital allocation programme through the end of 2029, starting with a launch of initial US$ 50 million share buyback and cancellation programme

Page 28

NAV per share 31-Mar-26 Lion Finance Group Operating performance FX & multiple change Emerging & other portfolio Buybacks Operating expenses Liquidity manag. /FX/Other NAV per share 30-Jun-26 NAV PER SHARE (GEL) MOVEMENT IN 2Q26 NAV PER SHARE (GEL) UP 13.1% Q-O-Q TO GEL 175.12 IN 2Q26 ▪ The increase in NAV per share (GEL) reflects excellent underlying operating performances across the large portfolio companies, as well as continued growth in Lion Finance Group’s share price ▪ In 2Q26, GCAP delivered IFRS net income of GEL 710.1 million in GBP: 43.34 +15.6% +9.4% +13.1%-0.3%+2.2% +0.3% 28 in GBP: 50.10 -0.9%+2.4% PRIVATE LARGE PORTFOLIO 0.0% 154.82 175.12

Page 29

AS OF 30 JUNE 2026, FIVE-YEAR NAV PER SHARE CAGR STOOD AT 26.3%, 30.9% AND 32.1% IN GEL, US$ AND GBP TERMS, RESPECTIVELY AS OF 30 JUNE 2026, THREE-YEAR NAV PER SHARE CAGR STOOD AT 33.7%, 33.2% AND 31.3% IN GEL, US$ AND GBP TERMS, RESPECTIVELY STRONG NAV PER SHARE GROWTH 44.32 46.84 48.12 54.48 63.03 65.56 73.28 82.94 95.95 154.68 154.82 175.12 Dec-18 Dec-19 Dec-20 Jun-21 Dec-21 Dec-22 Jun-23 Dec-23 Dec-24 Dec-25 Mar-26 Jun-26 NAV PER SHARE (GEL) DEVELOPMENT OVERVIEW CAGR since the demerger: 20.1% 29 Five-year CAGR: 26.3% Three-year CAGR: 33.7% ✓ SUSTAINED NAV PER SHARE DEVELOPMENT REINFORCES OUR LONG-TERM VALUE GROWTH PROPOSITION FOR OUR SHAREHOLDERS ✓ GEORGIA CAPITAL HAS BEEN AMONG THE BEST-PERFORMING STOCKS IN THE UK INVESTMENT COMPANIES SECTOR OVER THE PAST THREE AND FIVE YEARS, DELIVERING SHARE PRICE CAGR OF 65.0% AND 45.7%, RESPECTIVELY

Page 30

30 NAV PER SHARE DISCOUNT DEVELOPMENT OVERVIEW 13.05 13.53 14.81 13.78 12.46 7.41 8.41 9.18 10.81 9.97 12.45 14.16 15.10 12.92 14.78 18.55 20.12 21.41 22.12 23.44 24.23 26.48 22.10 22.82 27.14 29.80 33.61 37.25 42.44 43.34 50.10 21.8% 19.4% 26.4% 26.0% 26.0% 42.6% 44.7% 60.2% 50.0% 42.0% 42.2% 57.6% 52.8% 51.2% 59.0% 66.6% 63.7% 63.3% 62.4% 58.0% 57.8% 49.9% 55.7% 59.2% 55.8% 48.4% 42.8% 35.3% 27.0% 16.2% 16.6% Dec-18 Mar-19 Jun-19 Sep-19 Dec-19 Mar-20 Jun-20 Sep-20 Dec-20 Mar-21 Jun-21 Sep-21 Dec-21 Mar-22 Jun-22 Sep-22 Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24 Jun-24 Sep-24 Dec-24 Mar-25 Jun-25 Sep-25 Dec-25 Mar-26 Jun-26 NAV Per Share (GBP) NAV Discount DESPITE STRONG RECENT TRADING PERFORMANCE, THE PRIVATE PORTFOLIO NAV PER SHARE DISCOUNT REMAINS WIDE, PRESENTING AN ATTRACTIVE BUYBACK OPPORTUNITY +19.6% CAGR

Page 31

EARLY BOND REDEMPTION OF US$ 150 MILLION GEL 413 MILLION REPURCHASED & CANCELLED SHARES GEL 270 MILLION GEL 700 MILLION CAPITAL RETURN PROGRAMME CURRENTLY ONGOING SHARE BUYBACK GEL 28 MILLION THE EARLY COMPLETION OF THE CAPITAL RETURN PROGRAMME ONCE AGAIN DEMONSTRATES GCAP'S STRONG CASH FLOW GENERATION AND DISCIPLINED CAPITAL ALLOCATION TOGETHER, UPON COMPLETION OF THE CURRENT SHARE BUYBACK PROGRAMME, THESE TRANSACTIONS WILL MARK THE COMPLETION OF GCAP'S GEL 700 MILLION CAPITAL RETURN PROGRAMME, SIGNIFICANTLY AHEAD OF ITS ORIGINAL DECEMBER 2027 TIMELINE IN JUNE 2026, GCAP ANNOUNCED: COMPLETION OF GEL 700 MILLION CAPITAL RETURN PROGRAMME THE FULL EARLY REDEMPTION OF THE US$ 50 MILLION SUSTAINABILITY- LINKED LOCAL BONDS ISSUED BY ITS GEORGIAN HOLDING COMPANY. SETTLEMENT IS EXPECTED ON 19 AUGUST 2026, FOLLOWING WHICH GCAP WILL HAVE FULLY REPAID ITS OUTSTANDING HOLDING COMPANY DEBT AN EXTENSION OF ITS CURRENT SHARE BUYBACK AND CANCELLATION PROGRAMME, OF WHICH APPROXIMATELY US$ 11 MILLION REMAINS OUTSTANDING 2 1 31

Page 32

32 ROBUST CASH GENERATION 211 302 48 8 (69) 500 (190) 310 Cash and liquid funds 31-Mar-26 LFG sell-down Dividend Income Investments/ divestments Share repurchases Cash and liquid funds 30-Jun-26 Bond redemption and buyback extension Pro-forma cash and liquid funds 2.3% KEY DRIVERS OF CHANGE IN CASH AND LIQUID FUNDS CASH AND LIQUID FUNDS BALANCE UP 2.4X TIMES OVER THE QUARTER THE INCREASE WAS PRIMARILY DRIVEN BY: ✓ SELL-DOWN OF LION FINANCE GROUP SHARES IN LINE WITH OUR PFIC RISK MANAGEMENT STRATEGY ✓ SOLID DIVIDEND INCOME ✓ DISPOSAL OF HOUSING DEVELOPMENT BUSINESS GCAP’S STRONG CURRENT AND EXPECTED LIQUIDITY POSITION, COUPLED WITH A REDUCED RISK PROFILE, CREATES OPPORTUNITIES FOR FURTHER CAPITAL RETURNS AND GROWTH INVESTMENTS GEL MILLION following the US$ 50 million SLB redemption and US$ 10 million buyback extension c.310

Page 33

LAUNCH OF NEW GEL 1 BILLION CAPITAL ALLOCATION PROGRAMME 33 THE PROGRAMME IS UNDERPINNED BY GCAP’S DERISKED AND STRENGTHENED BALANCE SHEET, WITH NO HOLDCO-LEVEL BORROWINGS AND SUSTAINED NAV PER SHARE GROWTH IT IS EXPECTED TO BE FUNDED THROUGH A COMBINATION OF: ✓ EXISTING STRONG LIQUID FUNDS ✓ EXPECTED ROBUST FREE CASH FLOW GENERATION AT GCAP o Dividend inflows from Lion Finance Group o Dividend inflows from private portfolio companies THE PROGRAMME COVERS: GCAP ANNOUNCES THE LAUNCH OF A NEW GEL 1 BILLION CAPITAL ALLOCATION PROGRAMME, EXPECTED TO BE IMPLEMENTED AND COMPLETED BY THE END OF 2029 BUSINESS INVESTMENTS IN GEORGIA AND ARMENIA CAPITAL RETURNS - SHARE BUYBACKS AND POTENTIAL DIVIDENDS THE NEW PROGRAMME WILL COMMENCE FOLLOWING THE COMPLETION OF THE CURRENT SHARE BUYBACK PROGRAMME, STARTING WITH AN INITIAL US$ 50 MILLION SHARE BUYBACK PROGRAMME THE BOARD EXPECTS THAT AT LEAST HALF OF THE PROGRAMME WILL BE ALLOCATED TO CAPITAL RETURNS - SHARE BUYBACKS AND/OR DIVIDENDS

Page 34

SHARE BUYBACK AND CANCELLATION PROGRAMME 16.7 MILLION SHARES (US$ 295 MILLION IN VALUE) REPURCHASED AND CANCELLED SINCE DEMERGER IN 2018, REPRESENTING 35.0%1 OF THE ISSUED SHARE CAPITAL AT ITS PEAK DEVELOPMENT OF GCAP’S SHARE BUYBACK AND CANCELLATION PROGRAMMES Georgia Capital PLC | 1. Determined by taking into account the peak number of 47.9 million shares issued as of 31-Dec-20. 2. Represents shares issued during Georgia Healthcare Group (“GHG”) share exchange facility. $18 $36 $36 $43 $61 $80 $128 $239 $295 1.3 2.7 2.7 3.5 5.8 7.4 11.1 15.6 16.7 2018 Since demerger 2019 2020 2021 2022 2023 2024 2025 2026 to date Value of shares repurchased (cumulative, US$ million) Number of shares repurchased (cumulative, million) 39.4 40.2 47.92 47.1 44.8 43.2 39.5 34.9 33.8 Number of issued shares (million) ➢ Repurchased c.476,000 shares for a total consideration of GEL 68.5 million (US$ 25.5 million) in 2Q26 ➢ c.1,095,000 shares (US$ 55.6 million in value) repurchased to date in 2026, representing 3.1% of issued share capital as at the beginning of 2026 34

Page 35

LIQUIDITY OUTLOOK 74 54 88 234 152 40 99 89 85 196 124 Dec-19 Dec-20 Dec-21 Jun-22 Dec-22 Dec-23 Dec-24 Dec-25 Mar-26 Jun-26 Pro-forma LIQUIDITY DEVELOPMENT OVERVIEW (US$ MILLION) 35 GROSS DEBT (US$ million) LIQUIDITY INCREASED 2.3x TIMES Q-O-Q, DRIVEN BY: ✓ SELL-DOWN OF LION FINANCE GROUP SHARES ✓ DIVIDEND COLLECTIONS ✓ RECEIPT OF PROCEEDS FROM THE HOUSING DEVELOPMENT BUSINESS WHICH WERE PARTIALLY OFFSET BY SHARE BUYBACKSCancellation of US$ 65 million GCAP Eurobond LIQUIDITY OUTLOOK Full redemption of GCAP Eurobond Cash receipt from the 80% water utility business sale Jun-26 2 Georgia Capital PLC | 1. The figure includes accrued interim dividends from LFG (ex-dividend date in December 2025, payment date in January 2026). 2. The figure includes accrued interim dividends from LFG (ex-dividend date in June 2026, payment date in July 2026). Early redemption of US$ 100 million local holding bonds 1 Pro-forma 300 300300 365 365 150 150 50 50 50 0 Full early redemption of local holding bonds Early full redemption of SLB and buyback extension

Page 36

29 15 41 81 72 107 38 - 44 50 33 24 44 30 60 53 55 57 86 25 73 30 74 94 180 179 226 2019 2020 2021 2022 2023 2024 2025 Dividend income from listed companies Buyback dividend Dividend income from private companies 2026 c.200 OUTLOOK c.114 DIVIDEND INCOME OUTLOOK RECURRING CASH DIVIDEND INCOME FROM PORTFOLIO COMPANIES 36 GEL 46.7 MILLION RECURRING DIVIDEND INCOME IN 2Q26 GEL MILLION DIVIDEND INCOME (GEL million) 2Q26 1H26 Lion Finance Group 27.6 61.8 of which, cash dividend 18.3 38.0 of which, buyback dividend 9.3 23.7 Retail (pharmacy) 11.9 11.9 P&C insurance 6.3 11.6 Auto service 1.0 1.0 TOTAL 46.7 86.3 1 Georgia Capital PLC | 1. In 2023 and 2024, GCAP received one-off non-recurring inflows of GEL 56.1 million and GEL 22.6 million, respectively. c.200 GEL MILLION SOLID DIVIDEND INCOME OUTLOOK IN 2026 1 2.11.6 4.1 4.3 6.5 Dividend income per share (GEL) INCLUDES 1Q26 DIVIDEND FROM LFG RECEIVED IN JULY 2026

Page 37

Page 38

119 148 1H25 1H26 62 75 2Q25 2Q26 38 AGGREGATED REVENUE AND EBITDA DEVELOPMENT ACROSS LARGE PRIVATE PORTFOLIO AGGREGATED REVENUE DEVELOPMENT GEL MILLION AGGREGATED EBITDA DEVELOPMENT GEL MILLION439 523 869 1,012 2Q25 2Q26 1H25 1H26 +19.1% +16.4% +21.2% +23.9%

Page 39

14.3% 13.4% 11.4% 13.7% 19.1% 11.9% 11.4% 12.9% 11.5% 11.8% 2Q25 3Q25 4Q25 1Q26 2Q26 y-o-y revenue growth of large portfolio companies y-o-y nominal GDP growth 39 SUSTAINED DOUBLE-DIGIT AGGREGATED REVENUE GROWTH OF PRIVATE LARGE PORTFOLIO COMPANIES AGGREGATED REVENUE DEVELOPMENT ACROSS OUR PRIVATE LARGE PORTFOLIO AGGREGATE REVENUES OF OUR LARGE PRIVATE PORTFOLIO COMPANIES UP BY 19.1% Y-O-Y IN 2Q26, MARKING THE EIGHTH CONSECUTIVE QUARTER OF DOUBLE-DIGIT REVENUE GROWTH AGAINST THE BACKDROP OF CONTINUED ECONOMIC GROWTH IN GEORGIA, WITH NOMINAL GDP GROWTH PRELIMINARILY ESTIMATED AT 11.8% Y-O-Y IN 2Q26, OUR LARGE PRIVATE PORTFOLIO COMPANIES DELIVERED ANOTHER QUARTER OF STRONG GROWTH RELATIVE TO THE BROADER ECONOMY DOUBLE-DIGIT REVENUE GROWTH FOR THE EIGHTH CONSECUTIVE QUARTER

Page 40

AGGREGATED CASH BALANCE & NET OPERATING CASH FLOW DEVELOPMENT ACROSS LARGE PRIVATE PORTFOLIO AGGREGATED NET OPERATING CASH FLOW AGGREGATED CASH BALANCE 40 54 76 2Q25 2Q26 +41.4% 97 132 1H25 1H26 +36.2% 210 238 254 30-Jun-25 31-Mar-26 30-Jun-26 +6.8% +21.1% GEL MILLION GEL MILLION

Page 41

PORTFOLIO VALUE AS OF 30-JUN-26 Georgia Capital PLC | 1. In 2Q26, valuation assessments of our retail (pharmacy), healthcare services, insurance, renewable energy, and education businesses were performed by third-party independent valuation firm, in line with International Private Equity Valuation (“IPEV”) guidelines, as part of the semi-annual independent valuation cycle for these businesses. 2. LTM implied EV/EBITDA multiples for retail (pharmacy) and healthcare services are presented including IFRS 16 as of 30-Jun-26. 78% OF OUR PORTFOLIO IS VALUED EXTERNALLY1 2,537 2,334 542 Listed Large Emerging and other PORTFOLIO BREAKDOWN GEL 5,413 MILLION 10% 47% 43% 2,537 1,035 688 611 542 Lion Finance Group Retail (pharmacy) Healthcare services Insurance Emerging and other businesses % SHARE IN TOTAL PORTFOLIO VALUE: LARGE PORTFOLIO COMPANIES GEL MILLION 10%11% 9.9x LTM P/E 13% 10.4x LTM EV/EBITDA2 47% GBP 113.3 PRICE ON LSE 19% MULTIPLE: 8.3x LTM EV/EBITDA2 97% OF OUR PORTFOLIO IS VALUED EXTERNALLY1 LISTED 41

Page 42

9.8x 10.1x 9.5x 9.9x 30-Jun-25 31-Dec-25 31-Mar-26 30-Jun-26 INSURANCE 8.2x 8.1x 8.0x 8.3x 30-Jun-25 31-Dec-25 31-Mar-26 30-Jun-26 RETAIL (PHARMACY) 9.9x 10.1x 10.1x 10.4x 30-Jun-25 31-Dec-25 31-Mar-26 30-Jun-26 HEALTHCARE SERVICES 4242 PRIVATE LARGE PORTFOLIO IMPLIED MULTIPLE DEVELOPMENT

Page 43

222 (8) 5,045 154 5,413 Portfolio value 31-Mar-26 Lion Finance Group Large portfolio companies Other portfolio companies Portfolio value 30-Jun-26 PORTFOLIO VALUE DEVELOPMENT IN 2Q26 GEL MILLION PORTFOLIO UP BY 7.3% Q-O-Q TO GEL 5.4 BILLION IN 2Q26 43 LISTED PORTFOLIO UP BY 6.5% PRIVATE PORTFOLIO VALUE UP BY 8.1% PRIVATE PORTFOLIO 2Q26 VALUE CREATION GEL million Retail (pharmacy) 124.0 Healthcare services 66.8 Insurance 48.4 Emerging and other businesses 0.2 Total 239.4 Emerging and other portfolio companies LFG VALUE DEVELOPMENT IN 2Q26 GEL million Value as of 31-Mar-26 2,383.1 Value creation 484.1 Sell-down (302.2) Dividends (27.6) Value as of 30-Jun-26 2,537.5 154

Page 44

HEALTHCARE SERVICES 4444 PRIVATE LARGE PORTFOLIO VALUATION OVERVIEW 923 47 4 62 1,035 Equity Value 31-Mar-26 EBITDA change Net debt change FX & Multiple change Equity value 30-Jun-26 569 16 (0) 26 611 Equity Value 31-Mar-26 Net income change Net debt change Multiple change Equity value 30-Jun-26 620 45 (3) 25 688 Equity Value 31-Mar-26 EBITDA change Net debt change FX & Multiple change Equity value 30-Jun-26 Georgia Capital PLC | General note: In 2Q26, valuation assessments of our retail (pharmacy), healthcare services, insurance, renewable energy, and education businesses were performed by third-party independent valuation firm, in line with International Private Equity Valuation (“IPEV”) guidelines, as part of the semi-annual independent valuation cycle for these businesses. RETAIL (PHARMACY) INSURANCE GEL MILLION 8.0x MULTIPLE 8.3x MULTIPLE 9.5x MULTIPLE 9.9x MULTIPLE 10.1x MULTIPLE 10.4x MULTIPLE Includes GEL 6.3m dividend +5.0% +0.4% +6.7%Impact +2.8% 0.0% +4.6%Impact+7.3% -0.5%Impact +4.0% Includes GEL 11.9m dividend

Page 45

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY 03 2Q26 & 1H26 PERFORMANCE OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES CONTENTS 45

Page 46

LION FINANCE GROUP PLC OVERVIEW INVESTMENT RATIONALE • The first entity from Georgia to be listed on the premium segment of the Main Market of the LSE (LSE: BGEO) since February 2012 and to be included in FTSE 100 since March 2026. • High standards of transparency and governance. • Digital leader in banking sector with a strong retail banking franchise. • Sustainable growth combined with strong capital, liquidity and robust profitability, with ROAE above 20%. • Growing market: The banking sector’s y-o-y lending growth rate at 14.0% and 24.7% in Georgia and Armenia, respectively. VALUE CREATION POTENTIAL • 20%+ ROAE. • Annual loan book y-o-y growth c.15%. • Regular progressive semi-annual capital distribution with 30-50% dividend/share buyback payout ratio. • Significant additional growth potential of Ameriabank within Lion Finance Group by using its experience and know-how in retail products, digitalisation and payment business. OWNERSHIP • As of 30-Jun-2026 Georgia Capital owns 14.9% of Lion Finance Group PLC. As long as Georgia Capital’s stake in Lion Finance Group is greater than 9.9%, it will exercise its voting rights in Lion Finance Group in accordance with the votes cast by all other shareholders on all shareholder votes at any general meeting. https://lionfinancegroup.uk/ https://lionfinancegroup.uk/ LEADING MARKET POSITION IN GEORGIA AND ARMENIA As of 31-Mar-26 Georgia Armenia Loans 38.0% 22.0% Deposits 40.6% 19.5% ROAE 20%+ LOAN BOOK GROWTH C.15% KEY MEDIUM-TERM TARGETS 46

Page 47

184 347 360 402 459 122 73 188 162 181 203 55 257 535 2021 2022 2023 2024 2025 1Q26 Cash dividend for the period Share buyback and cancellation 522 583 662 177 24.5% 15.9% 21.4% 27.0% 18.9% 13.9% 4.3% 20.0% 20.5% 15.9% 17.5% 16.1% 17.4% 19.0% 22.0% 10.2% 19.8% 12.9% 19.6% 19.3% 16.1% 17.8% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1Q26 Loan book growth (nominal) Loan book growth (constant currency basis) 296 370 379 514 295 727 1,132 1,375 1,813 2,193 585 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1Q26 47 5.00 25.00 45.00 65.00 85.00 105.00 125.00 May/18 Jun/18 Jul/18 Aug/18 Sep/18 Oct/18 Nov/18 Dec/18 Jan/19 Feb/19 Mar/19 Apr/19 May/19 Jun/19 Jul/19 Aug/19 Sep/19 Oct/19 Nov/19 Dec/19 Jan/20 Feb/20 Mar/20 Apr/20 May/20 Jun/20 Jul/20 Aug/20 Sep/20 Oct/20 Nov/20 Dec/20 Jan/21 Feb/21 Mar/21 Apr/21 May/21 Jun/21 Jul/21 Aug/21 Sep/21 Oct/21 Nov/21 Dec/21 Jan/22 Feb/22 Mar/22 Apr/22 May/22 Jun/22 Jul/22 Aug/22 Sep/22 Oct/22 Nov/22 Dec/22 Jan/23 Feb/23 Mar/23 Apr/23 May/23 Jun/23 Jul/23 Aug/23 Sep/23 Oct/23 Nov/23 Dec/23 Jan/24 Feb/24 Mar/24 Apr/24 May/24 Jun/24 Jul/24 Aug/24 Sep/24 Oct/24 Nov/24 Dec/24 Jan/25 Feb/25 Mar/25 Apr/25 May/25 Jun/25 Jul/25 Aug/25 Sep/25 Oct/25 Nov/25 Dec/25 Jan/26 Feb/26 Mar/26 Apr/26 May/26 Jun/26 Stock price performance GEL million 25.2% 26.4%ROAE 26.1% 13.0% 25.8% 32.4%22.2% Georgia Capital PLC | General note: certain numbers have been adjusted for presentation purposes. For details, please refer to the Lion Finance Group's disclosures at https://lionfinancegroup.uk/. 1. Reflects the loan book growth of JSC Bank of Georgia. 29.9% 30.0% Capital distribution (GEL million) Loan book growth1Profit & ROAE 28.4% GBP 113.30 as of 30-Jun-26 LION FINANCE GROUP PLC OVERVIEW (CONT’D) https://lionfinancegroup.uk/ https://lionfinancegroup.uk/ The board has approved an extension to the buyback and cancellation programme of GEL 55.0 million, alongside an interim dividend of GEL 2.85 per share in respect of 1Q26. 27.4%

Page 48

RETAIL (PHARMACY) BUSINESS OVERVIEW 48 GEORGIA’S LARGEST RETAILER IN TERMS OF REVENUE WITH 34% MARKET SHARE IN ORGANISED RETAIL MARKET1 Georgia Capital PLC | 1. Based on 2024 revenues. 2. Includes 2 pharmacy chains. 3. In 2026, revenue generated under state-funded programmes and sold through retail channels has been reclassified from wholesale to retail revenue, considering that retail serves as the distribution channel for such sales. Comparative periods and respective operating data have been restated accordingly. RETAIL BUSINESS PORTFOLIO | JUNE 2026 Pharmacies in total +6 Q-O-Q 464 20 in Armenia 444 in Georgia 14 The Body Shop stores 7 in Georgia 2 in Armenia 5 in Azerbaijan ✓ In 2Q26, the retail pharmacy chain expanded by 6 pharmacies, with openings focused on strategically selected locations 5 Optics – Alain Afflelou 1 in Armenia 4 in Georgia ORGANISED RETAIL MARKET SHARE | 2024 REVENUE 6% 30% 34% 30% 125.3 624.6 633.7 PHARMADEPOT - 482.6 GPC – 219.9 Other² PSP Aversi GCAP in pharma 702.5 GEL MILLION GCAP’s retail (pharmacy) business 189 215 380 422 35 41 70 78 224 256 450 500 2Q25 2Q26 1H25 1H26 Retail Wholesale +14.1% 32.5% 34.0%32.7% 34.1% Gross Profit Margin +13.7% +11.6% REVENUE DEVELOPMENT, GEL MILLION3 +11.2% 17.1 17.28.4 8.8 Number of bills issued (million) 22.4 24.5 22.2 24.5 2Q25 2Q26 1H25 1H26 +9.3% +10.1% AVERAGE BILL SIZE, GEL3 SAME STORE REVENUE GROWTH3 1H26 RETAIL REVENUE BY CATEGORIES +16.5% +11.1% 2Q25 7.9% 2Q26 8.5% 1H25 5.3% 1H26 6.5% GEL 422 MILLION PRESCRIPTION 31% OVER THE COUNTER 24% FOOD SUPPLEMENT 12% BABY CARE & FOOD 10% COSMETICS & OTHER 23% BEAUTY & OTHER 45% GEL 189 MLN MEDICINE 55% GEL 233 MLN

Page 49

RETAIL (PHARMACY) BUSINESS PERFORMANCE OVERVIEW (CONT’D) 49 GEL MILLION EBITDA EBITDA margin 24.4 29.8 48.5 58.9 2Q25 2Q26 1H25 1H26 10.9% 11.7% 10.8% 11.8% +22.3% +21.4% ✓ ACHIEVED Y-O-Y EBITDA GROWTH OF 22.3% IN 2Q26 OPERATING CASH FLOW EBITDA to cash conversion 63.8% 88.1% 89.3% 100.9% ✓ EBITDA TO CASH CONVERSION STOOD AT 88.1% IN 2Q26, REFLECTING THE STRONG BUSINESS PERFORMANCE 15.5 26.2 43.3 59.5 2Q25 2Q26 1H25 1H26 +69.0% +37.2% ADJUSTED NET DEBT TO LTM EBITDA1 Georgia Capital PLC | General note: Figures are given excluding IFRS 16 effect; 1. Figures take into account the application of the minority buyout agreement. 136.7 130.3 128.3 102.5 94.5 1.4x 1.3x 1.3x 1.0x 0.8x 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 Jun-25 Sep-25 Dec-25 Mar-26 Jun-26 Adjusted net debt Adjusted net debt to LTM EBITDA ✓ ADJUSTED NET DEBT TO LTM EBITDA STANDS AT 0.8x AS OF JUNE 2026, BELOW THE TARGETED LEVEL OF 1.5x ✓ GEL 11.9 MILLION DIVIDENDS PAID TO GCAP IN 2Q26

Page 50

3 ROBUST CASH GENERATION REFLECTED IN 88.1% EBITDA-TO-CASH CONVERSION AND PRUDENT LEVERAGE WITH ADJUSTED NET DEBT TO EBITDA AT 0.8x. THE BUSINESS DISTRIBUTED GEL 11.9 MILLION DIVIDENDS TO GCAP IN 2Q26 (GEL 10.0 MILLION IN 2Q25) 2 ENHANCED PROFITABILITY, SUPPORTED BY A SHIFT IN THE SALES MIX TOWARD HIGHER-MARGIN PRODUCT PORTFOLIO AND IMPROVED SUPPLIER TERMS, DRIVING SIGNIFICANT GROSS PROFIT AND EBITDA GROWTH 1 STRONG TOP-LINE PERFORMANCE SUPPORTED BY 8.5% SAME-STORE REVENUE GROWTH IN 2Q26 AND ROBUST PERFORMANCE OF WHOLESALE BUSINESS 50 RETAIL (PHARMACY) BUSINESS KEY CONSIDERATIONS

Page 51

55 67 107 12763 73 127 143 - 50 100 150 200 250 300 2Q25 2Q26 1H25 1H26 outpatient inpatient 3.9 3.8 3.7 3.7 3.5 0 2 4 6 8 10 83 90 93 97 103 0 50 100 150 Jun-25 Sep-25 Dec-25 Mar-26 Jun-26 24 30 47 57 0 10 20 30 40 50 60 2Q25 2Q26 1H25 1H26 HEALTHCARE SERVICES BUSINESS OVERVIEW 51 2Q26 AND 1H26 KEY HIGHLIGHTS: GEL MILLION EBITDA1NET REVENUE +20.4% Georgia Capital PLC | 1. EBITDA, net debt and EBITDA margin (%) are presented excluding IFRS 16 impact. HEALTHCARE BUSINESS PORTFOLIO ✓ EXPANDED SERVICE OFFERINGS ACROSS TBILISI AND THE REGIONS ✓ NEW DOCTORS ONBOARDED ✓ LAB RETAIL NETWORK FURTHER EXPANDED, REACHING 20 TOTAL RETAIL BRANCHES ✓ NET REVENUE FROM OUTPATIENT SERVICES UP 21.6% AND 18.6% Y-O-Y IN 2Q26 AND 1H26, RESPECTIVELY ✓ DELIVERED 16% TOP-LINE AND 20% EBITDA GROWTH Y-O-Y IN 1H26 LTM EBITDA AND NET DEBT TO LTM EBITDA1 GEL MILLION +15.9% 118 JUNE 2026 Hospitals 35 16 Polyclinics 1 Laboratory WC/Revenue, % 21.5% 17.9% +25.1% x x x x x +17.9% 139 234 271 15.8% 17.0% 19.5% 20.7% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% FY23 FY24 FY25 1H26 EBITDA MARGIN1

Page 52

69.1% 71.1% 72.2% 69.7% 62.0% 64.0% 66.0% 68.0% 70.0% 72.0% 74.0% 76.0% 78.0% 80.0% 2Q25 2Q26 1H25 1H26 18 23 37 43 - 10 20 30 40 50 2Q25 2Q26 1H25 1H26 16 19 24 27 - 10 20 30 2Q25 2Q26 1H25 1H26 97 114 191 222 - 50 100 150 200 250 2Q25 2Q26 1H25 1H26 52 HOSPITALS BUSINESS 2Q26 AND 1H26 KEY HIGHLIGHTS: GEL MILLIONGEL MILLION Georgia Capital PLC | 1. EBITDA and operating cash flow are presented excluding IFRS 16 impact. 2. Operating highlights include preliminary operating data from Gormed. OPERATING HIGHLIGHTS - BED OCCUPANCY RATES (%) Average length of stay (days) NET REVENUE EBITDA1 OPERATING CASH FLOWS1 +18.3% +17.0% 10,366 308 497 779 813 839 2,460 Other Ingorokva Tbilisi Medical Institute Ghudushauri-Chachava Geo Hospitals Aversi State GCAP Hospitals HOSPITALS MARKET SHARES | NUMBER OF HOSPITAL BEDS* 65% 2% 3% 5% 5% 5% 15% *Total number of beds amounts to 16,062 HEALTHCARE SERVICES BUSINESS PERFORMANCE OVERVIEW 4.4 3.9 87.9% 62.6% EBITDA to cash conversion (excl. IFRS 16) 2 EBITDA margin (excl. IFRS 16) ✓ Revenue growth of 18% in 2Q26, supported by expansion of outpatient services, which increased by 21% ✓ Operating cash flow reflects seasonality patterns in state cash collections ✓ Average length of stay reduced by 0.6 days (1H26 vs 1H25) 18.7% 19.8%+16.2% +23.9% +17.9% 18.9% 19.2% +14.0% 83.0% 64.8% -2.5 ppts 3.9 4.5 +2.0 ppts WC/Revenue, % 22.4% 19.7%

Page 53

3.6 4.2 7.8 8.3 - 2.0 4.0 6.0 8.0 10.0 2Q25 2Q26 1H25 1H26 485 513 988 1,003 - 500 1,000 1,500 2Q25 2Q26 1H25 1H26 5 7 11 13 - 2 4 6 8 10 12 14 16 2Q25 2Q26 1H25 1H26 23 27 46 53 - 10 20 30 40 50 60 2Q25 2Q26 1H25 1H26 HEALTHCARE SERVICES BUSINESS PERFORMANCE OVERVIEW (CONT’D) 53 CLINICS & DIAGNOSTICS 2Q26 AND 1H26 KEY HIGHLIGHTS: GEL MILLIONGEL MILLION Georgia Capital PLC | 1. EBITDA and operating cash flow are presented excluding IFRS 16 impact. OPERATING HIGHLIGHTS EBITDA1 OPERATING CASH FLOWS1 NUMBER OF ADMISSIONS (THOUSANDS) - POLYCLINICS NUMBER OF TESTS PERFORMED (MILLION) - DIAGNOSTICS +16.8% +26.4% +16.6% +5.7% 136,828 323,910 416,452 423,723 Other Medcapital Geo Hospitals GCAP Polyclinics GCAP Regional & Community Clinics CLINICS MARKET SHARES | NUMBER OF REGISTERED PATIENTS 59% 4% 14% 1,809,453 13% 10% *Total number of registered patients amounts to 3,110,366 22.8% 24.7% EBITDA margin (excl. IFRS 16) 67.2% 61.4% EBITDA to cash conversion (excl. IFRS 16) 27% ✓ Number of admissions in polyclinics increased by 6% y-o-y in 2Q26 ✓ Number of registered patients in polyclinics increased by c.10,000 y-o-y ✓ Net revenue grew by 17% y-o-y in 2Q26 ✓ EBITDA growth amounted to 26% y-o-y in 2Q26 GCAP Polyclinics GCAP Regional & Community Clinics +15.4% NET REVENUE +27.4% 23.0% 25.4% +5.8% 62.0% 73.9% +1.5% 0.7 0.7 1.4 1.4 - 1.0 2.0 2Q25 2Q26 1H25 1H26 +3.6% +3.5% WC/Revenue, % 6.1% 8.5%

Page 54

54 2 1 EXPANDED MEDICAL INFRASTRUCTURE, STRENGTHENED CLINICAL TEAMS AND ADDED NEW COMPLEX SURGICAL AND OTHER SERVICES WITHIN GHG NETWORK DELIVERED 18% Y-O-Y TOP-LINE GROWTH IN 2Q26 3 HEALTHCARE SERVICES BUSINESS KEY CONSIDERATIONS EBITDA GROWTH AMOUNTED TO 25%, WITH EBITDA MARGIN IMPROVING BY 1.4 PPTS Y-O-Y IN 2Q26

Page 55

44 49 53 79 2Q-25 2Q-26 P&C Medical 55 INSURANCE BUSINESS OVERVIEW INSURANCE BUSINESS COMPRISES TWO BUSINESS LINES: INSURANCE REVENUE GEL MILLION +32% GEL MILLION +34% ADJUSTED PRE-TAX PROFIT1, 2 PROPERTY AND CASUALTY (P&C) KEY OPERATING HIGHLIGHTS 2Q26 CHANGE y-o-y 1H26 CHANGE y-o-y NPW, P&C 62 21% 105 15% NPW, Medical 69 55% 223 68% NPW, Total Insurance 131 37% 327 47% 97 128 GEL MILLION Georgia Capital PLC | 1. Excluding ARDI acquisition-related interest expense allocation to medical insurance business. 2. The figures are presented excluding GEL 3.0 million motor insurance claims’ effect following a severe hailstorm in Tbilisi. 2Q25 2Q26 82 92 104 149 6M25 6M261H25 1H26 +30% 186 241 MEDICAL 9 8 5 8 2Q-25 2Q-26 P&C Medical GEL MILLION +13% PRE-TAX PROFIT1 14 16 2Q25 2Q26 16 17 8 16 6M25 6M261H25 1H26 +36% 24 32 9 11 5 8 2Q25 2Q26 14 19 16 20 8 16 1H25 1H26 +49% 24 36

Page 56

44 49 2Q-25 2Q-26 16 17 6M25 6M26 9 8 2Q-25 2Q-26 82 92 6M25 6M26 18% 2% 9% 18% 24% 29% INSURANCE BUSINESS OVERVIEW – P&C INSURANCE 56 ALDAGI IS A LEADING PLAYER IN PROPERTY AND CASUALTY INSURANCE INSURANCE REVENUE ✓ THE Y-O-Y INCREASE IN 2Q26 REVENUE REFLECTS: 1) INCREASE IN PROPERTY INSURANCE REVENUES DUE TO THE EXPANSION IN CORPORATE CLIENT PORTFOLIO, 2) GROWTH IN CREDIT LIFE INSURANCE LINE, AND 3) EXPANSION OF RETAIL AND CORPORATE MOTOR PORTFOLIOS, COUPLED WITH INCREASE IN CORPORATE INSURANCE POLICY PRICES PRE-TAX PROFIT (GEL MILLION) ✓ THE Y-O-Y INCREASE IN 2Q26 COMBINED RATIO PRIMARILY REFLECTS GEL 3.0 MILLION OF MOTOR INSURANCE CLAIMS ARISING FROM THE SEVERE HAILSTORM IN TBILISI. EXCLUDING T HIS ONE-OFF EVENT, THE 2Q26 COMBINED RATIO WOULD HAVE IMPROVED BY 1.5 PPTS Y-O-Y TO 82.9% GEL MILLION +11% 36.1% 27.5% -11% (+23% 1) GEL MILLION ROAE 2Q26 CHANGE Y-O-Y 1H26 CHANGE Y-O-Y NPW (GEL million) 62 21% 105 15% Combined Ratio 89.2% 4.8 ppts 87.6% 1.7 ppts Combined Ratio1 82.9% -1.5 ppts 84.2% -1.7 ppts Individuals Insured 144K 11% 144K 11% Policies Written 132K 29% 240K 22% Retail Renewal 79.6% 3.3 ppts 79.9% 2.1 ppts P&C MARKET SHARES | 1Q26 GROSS PREMIUMS WRITTEN (GEL MILLION) KEY OPERATING METRICS 1H25 1H26 37 4 20 38 49 60 Other Unison Global Benefits Georgia Vienna Insurance Group TBC Insurance P&C BusinessP&C Business ✓ P&C MARKET SHARE TENDS TO BE LOWER IN THE FIRST QUARTER, AS THE LARGE ACCOUNTS OF THE PORTFOLIO ARE PREDOMINANTLY RENEWED IN THE UPCOMING QUARTERS 32.4% 29.9% +6% (+25%1) 2Q25 2Q26 +12% 1H25 1H262Q25 2Q26 ✓ EXCLUDING HAILSTORM EVENT-RELATED MOTOR INSURANCE CLAIMS OF GEL 3.0 MILLION, P&C INSURANCE BUSINESS WAS UP BY 23% AND 25% Y-O-Y IN 2Q26 AND 1H26, RESPECTIVELY ✓ GEL 6.3 MILLION DIVIDENDS WERE PAID TO GCAP IN 2Q26 (GEL 11.6 MILLION IN 1H26) FLAT Y-O-Y Georgia Capital PLC | 1. The figures are presented excluding GEL 3.0 million motor insurance claims’ effect following a severe hailstorm in Tbilisi.

Page 57

2Q26 CHANGE Y-O-Y NPW (GEL million) 69 55% Combined Ratio 92.2% -1.0 ppts Individuals Insured 372K 38% Renewal Rate 77.1% -5.3 ppts 104 149 6M25 6M26 53 79 2Q-25 2Q-26 INSURANCE BUSINESS OVERVIEW – MEDICAL INSURANCE Georgia Capital PLC | 1. Excluding ARDI acquisition-related interest expense allocation to medical insurance business. 57 ✓ THE Y-O-Y IMPROVEMENT IN THE 2Q26 COMBINED RATIO MAINLY REFLECTS A LOWER EXPENSE RATIO AS HIGHER INSURANCE REVENUE IMPROVED OPERATING LEVERAGE MEDICAL INSURANCE MARKET SHARE | 1Q26 GROSS PREMIUMS WRITTEN GEL MILLION KEY OPERATING METRICS INSURANCE REVENUE GEL MILLION ✓ 49% Y-O-Y GROWTH IN 2Q26 REVENUES PRIMARILY REFLECTS NEWLY AWARD ED TENDERS AND ORGANIC GROWTH IN THE CORPORATE PORTFOLIO, SUPPLEMENTED BY A MID-TEENS PERCENTAGE INCREASE IN INSURANCE POLICY PRICES AND RETAIL HEALTH PORTFOLIO EXPANSION 17% 8% 9% 17% 49% PRE-TAX PROFIT & ROAE 51 24 27 48 142 Other Global Benefits Georgia TBC Insurance Vienna Insurance Group Medical Insurane BusinessMedical Insurance Business ✓ MARKET SHARE INCREASED BY 16 PPTS Y-O-Y, PRIMARILY REFLECTING HIGHER MEDICAL TENDER PREMIUMS AND STRONG GROWTH IN THE RETAIL HEALTH SEGMENT DURING 1Q26 +49% +43% 1H25 1H262Q25 2Q26 GEL MILLION 5 8 2Q-25 2Q-26 8 16 6M25 6M26 32.6% 44.5%ROAE 24.6% 46.0% +53% +98% 1H26 CHANGE Y-O-Y 223 68% 91.7% -4.1 ppts 372K 38% 78.0% -3.6 ppts 1 ✓ TENDERS: • Medical tender premiums increased by GEL 13.8 million in 2Q26 (GEL 72.5 million in 1H26), reflecting tariff adjustments and enhanced underwriting criteria, with a positive impact on overall loss ratio and profitability ✓ RETAIL: • Retail health insured count reached 16,400, driving a GEL 1.6 million increase (+44%) in premiums in 2Q26 (GEL 4.4 million increase in 1H26, +60%) • The introduction of mandatory inbound travel insurance generated GEL 1.6 million GPW in 2Q26 (GEL 3.1 million in 1H26) and, given its low loss ratio, provided a profitable and diversifying contribution to retail health ✓ CORPORATE: • Mid-teens percentage increase in insurance tariffs supporting overall corporate profitability +16 PPTS Y-O-Y 2Q25 2Q26 1H25 1H26

Page 58

2 MEDICAL INSURANCE CONTINUED TO DELIVER STRONG 53% Y-O-Y GROWTH IN PROFIT, DRIVEN BY NEWLY AWARDED TENDERS, RETAIL HEALTH EXPANSION AND DISCIPLINED PRICING, SUPPORTING FURTHER IMPROVEMENT IN PROFITABILITY 3 TOTAL INSURANCE REVENUE GREW BY 32% Y-O-Y IN 2Q26, WHILE PRE-TAX PROFIT INCREASED BY 13% Y-O-Y DESPITE THE HAILSTORM IMPACT, DEMONSTRATING THE RESILIENCE OF THE DIVERSIFIED PORTFOLIO 1 UNDERLYING P&C PROFITABILITY REMAINED STRONG, WITH 2Q26 PROFIT IMPROVING BY 23% Y-O-Y, EXCLUDING THE GEL 3.0 MILLION ONE-OFF HAILSTORM-RELATED MOTOR CLAIMS 58 INSURANCE BUSINESS KEY CONSIDERATIONS 4 GEL 6.3 MILLION DIVIDENDS PAID TO GCAP IN 2Q26

Page 59

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY 03 2Q26 & 1H26 PERFORMANCE OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES CONTENTS 59

Page 60

RESILIENT MACROECONOMIC PERFORMANCE DESPITE UNCERTAINTIES 60 GEORGIA’S ECONOMY STARTED 2026 WITH STRONG MOMENTUM, POSTING 7.9% GDP GROWTH IN 1H26 Georgia Capital PLC | Source: Geostat, NBG GROSS INTERNATIONAL RESERVES REACHED A RECORD HIGH OF US$ 7.1 BILLION IN JUNE 2026, UP BY 52% Y-O-Y INFLATION IS EXPECTED TO STAY RELATIVELY HIGH IN 2026, MAINLY DRIVEN BY HIGHER OIL AND FOOD PRICES 49.7 104.6 4.7 4.3 5.1 6.7 8.3 9.2 10.3 5.4% -6.3% 10.6% 11.0% 7.8% 9.7% 7.5% 9.0% 7.0% -15 5 25 45 65 85 105 2019 2020 2021 2022 2023 2024 2025 1Q26 2Q26* Nominal GDP, GEL bln (LHS) GDP Per Capita, USD THS (LHS) Real GDP, YoY % (RHS) 73 100 265 430 164 34 26 -48 -301 -461 -598 -332 -214 147 64 438 -102 -778 -837 -500 -1,579 3.5 3.6 3.4 3.8 4.1 4.3 3.9 4.3 4.7 4.3 6.2 7.1 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25 1Q26 2Q26 NBG Net Interventions, US$ mln (RHS) Reserve Assets,EoP,US$ bln (LHS) THE CURRENT ACCOUNT DEFICIT REMAINED LOW AT 3.8% OF GDP IN 1Q26, REFLECTING BROAD- BASED IMPROVEMENTS ACROSS ALL COMPONENTS -6.7% -6.0% -12.4% -10.3% -4.4% -5.5% -5.3% -2.6% -7.9% -3.8% 7.5% 7.8% 3.7% 6.7% 8.9% 6.3% 4.6% 4.4% 0 2.3% 3.0% -28% -18% -8% 2% 12% 22% 2018 2019 2020 2021 2022 2023 2024 2025 1Q25 1Q26 Goods, net Services, net Investment income, net Current transfers, net Current account FDI, inflows *Preliminary estimated real GDP growth. 5.5 3.8 8.25 0 2 4 6 8 10 12 14 Mar-22 May-22 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Sep-23 Nov-23 Jan-24 Mar-24 May-24 Jul-24 Sep-24 Nov-24 Jan-25 Mar-25 May-25 Jul-25 Sep-25 Nov-25 Jan-26 Mar-26 May-26 Jul-26 Headline Inflation Core Inflation Target Monetary Policy Rate

Page 61

RESILIENT MACROECONOMIC PERFORMANCE DESPITE UNCERTAINTIES 61 GEORGIA’S ECONOMY STARTED 2026 WITH STRONG MOMENTUM, POSTING 7.9% GDP GROWTH IN 1H26 Georgia Capital PLC | Source: Geostat, NBG GROSS INTERNATIONAL RESERVES REACHED A RECORD HIGH OF US$ 7.1 BILLION IN JUNE 2026, UP BY 52% Y-O-Y INFLATION IS EXPECTED TO STAY RELATIVELY HIGH IN 2026, MAINLY DRIVEN BY HIGHER OIL AND FOOD PRICES 49.7 104.6 4.7 4.3 5.1 6.7 8.3 9.2 10.3 5.4% -6.3% 10.6% 11.0% 7.8% 9.7% 7.5% 9.0% 7.0% -15 5 25 45 65 85 105 2019 2020 2021 2022 2023 2024 2025 1Q26 2Q26* Nominal GDP, GEL bln (LHS) GDP Per Capita, USD THS (LHS) Real GDP, YoY % (RHS) 73 100 265 430 164 34 26 -48 -301 -461 -598 -332 -214 147 64 438 -102 -778 -837 -500 -1,579 3.5 3.6 3.4 3.8 4.1 4.3 3.9 4.3 4.7 4.3 6.2 7.1 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25 1Q26 2Q26 NBG Net Interventions, US$ mln (RHS) Reserve Assets,EoP,US$ bln (LHS) THE CURRENT ACCOUNT DEFICIT REMAINED LOW AT 3.8% OF GDP IN 1Q26, REFLECTING BROAD- BASED IMPROVEMENTS ACROSS ALL COMPONENTS -6.7% -6.0% -12.4% -10.3% -4.4% -5.5% -5.3% -2.6% -7.9% -3.8% 7.5% 7.8% 3.7% 6.7% 8.9% 6.3% 4.6% 4.4% 0 2.3% 3.0% -28% -18% -8% 2% 12% 22% 2018 2019 2020 2021 2022 2023 2024 2025 1Q25 1Q26 Goods, net Services, net Investment income, net Current transfers, net Current account FDI, inflows *Preliminary estimated real GDP growth. 5.5 3.8 8.25 0 2 4 6 8 10 12 14 Mar-22 May-22 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Sep-23 Nov-23 Jan-24 Mar-24 May-24 Jul-24 Sep-24 Nov-24 Jan-25 Mar-25 May-25 Jul-25 Sep-25 Nov-25 Jan-26 Mar-26 May-26 Jul-26 Headline Inflation Core Inflation Target Monetary Policy Rate

Page 62

UNEMPLOYMENT REMAINS AT HISTORICAL LOWS AT 13.9% IN 2025 LABOUR FORCE STRUCTURE AVERAGE MONTHLY NOMINAL EARNINGS OF EMPLOYEES AMOUNTED TO GEL 2,283 IN 2025 62 UNEMPLOYMENT RATE AT HISTORICAL LOWS Georgia Capital PLC | Source: Geostat 598 636 713 773 818 900 940 999 1,068 1,129 1,191 1,305 1,543 1,767 1,971 2,283 2,170 2,364 7.3% 6.4% 8.5% 5.8% 10.1% 4.4% 6.3% 5.7% 9.5% 18.3% 14.5% 11.5% 15.8% 11.7% 8.9% 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1Q25 1Q26 Wages, total, GEL Growth rate of wages Y-o-Y, (RHS) 1,168 1,183 1,212 1,198 1,255 1,308 1,295 1,287 1,296 1,296 1,242 1,217 1,284 1,335 1,402 1,390 1,394 1,369 436 442 442 430 374 367 359 354 309 277 282 316 268 262 227 224 239 230 1,604 1,625 1,655 1,627 1,629 1,676 1,654 1,641 1,605 1,573 1,524 1,534 1,552 1,596 1,629 1,614 1,634 1,599 51% 53% 54% 54% 54% 56% 55% 54% 53% 52% 50% 51% 52% 53% 55% 54% 55% 53% 50% 52% 54% 56% 58% 60% Thousand persons Employed Unemployed Labor force Labour force participation rate,% 19.7% 16.8% 18.3% 17.0% 21.9% 19.5% 19.4% 16.1% 16.7% 15.3% 13.7% 13.8% 14.7% 13.3% 14.4% 0.4% 2.7% 3.5% -8.5% -3.6% 6.7% -1.7% 1.8% 4.7% 10.3% 15.6% 12.9% 9.0% 9.6% 7.2% 8.8% 5.6% 6.3% 4.2% -10% -5% 0% 5% 10% 15% 20% 25% 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25 1Q26 Unemployment rate Wage real growth rate, Y-o-Y

Page 63

HEADLINE INFLATION REACHED 5.5% IN JULY 2026, AVERAGING 5.2% IN 7M26 INFLATION IS EXPECTED TO REMAIN RELATIVELY HIGH IN 2026 AMID GEOPOLITICAL UNCERTAINTIES 63Georgia Capital PLC | Source: NBG, Geostat DECOMPOSITION OF INFLATION FOOD INFLATION SOFTENED AMID BASE EFFECTS, WHILE SERVICES INFLATION CONTINUED TO INCREASE 5.1 5.9 4.4 -5 0 5 10 15 20 % % Food Inflation (Left Axis) Goods Inflation (Left Axis) Service Inflation (Right Axis) 11.5 10.6 9.8 8.1 5.3 2.7 0.6 0.9 0.8 0.4 0.3 1.5 2.2 1.0 0.3 1.9 2.4 3.4 4.0 4.6 5.2 4.0 4.8 4.3 5.9 5.8 5.5 -4 -2 0 2 4 6 8 10 12% Domestic Imported Mixed Headline Inflation 5.2% 9.6% 11.9% 2.5% 1.1% 3.9% 5.2% 5.2% 6.4% 6.3% 3.9% 1.7% 2.4% 3.2% 8.0% 10.5% 11.0% 9.5% 8.0% 8.0% 8.25% 0% 2% 4% 6% 8% 10% 12% 14% 2020 2021 2022 2023 2024 2025 7M26 Headline Inflation Core Inflation End of Period Monetary Policy Rate FOOD, TRANSPORT, AND UTILITIES WERE THE MAIN CONTRIBUTORS TO ANNUAL INFLATION -2 0 2 4 6 8 10 12 14 % Food and non-alcoholic beverages Alcoholic beverages and tobacco Housing and utilities Health Transport Other Headline Inflation

Page 64

Georgia Capital PLC | Source: NBG, Geostat 64 BROAD-BASED IMPROVEMENT ACROSS ALL COMPONENTS KEEPS THE CURRENT ACCOUNT DEFICIT LOW THE CURRENT ACCOUNT DEFICIT NARROWING TO -3.8% OF GDP IN 1Q26, DRIVEN BY BROAD-BASED IMPROVEMENTS ACROSS ALL COMPONENTS FX INFLOWS REMAIN ON AN UPWARD TRAJECTORY, RISING 17% IN 1Q26 EXPORT OF SERVICES INCREASED TO US$ 1.8 BILLION IN 1Q26 (+7.3% Y-O-Y), MAINLY DUE TO THE INCREASING ICT SERVICES EXPORT (60% Y-O-Y) FDI INFLOWS INCREASED BY 48% Y-O-Y IN 1Q26, REACHING 3.0% OF GDP 0.6 1.1 0.6 1.1 0.7 1.4 0.8 1.6 0.9 1.5 0.7 0.3 0.3 0.9 0.8 1.2 2.0 1.7 2.2 1.6 1.9 2.4 1.8 1.7 2.0 2.7 2.1 1.8 0 1 1 2 2 3 3 1Q15 3Q15 1Q16 3Q16 1Q17 3Q17 1Q18 3Q18 1Q19 3Q19 1Q20 3Q20 1Q21 3Q21 1Q22 3Q22 1Q23 3Q23 1Q24 3Q24 1Q25 3Q25 1Q26 Travel ICT services Transport Other services Services Export from BOP, bln USD 2.2 2.1 2.7 3.4 3.8 3.3 4.2 5.6 6.1 6.6 7.3 1.4 1.7 1.1 1.2 1.4 1.6 1.7 1.9 2.3 4.4 4.1 3.4 3.6 0.8 0.9 1.9 2.1 2.7 3.2 3.3 0.5 1.2 3.5 4.1 4.4 4.7 0.8 0.8 6.9 7.0 8.8 9.5 10.2 6.4 9.1 15.7 16.3 15.9 17.3 3.2 3.7 46% 46% 54% 53% 58% 40% 48% 63% 53% 47% 45% 40% 41% 0% 10% 20% 30% 40% 50% 60% 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1Q25 1Q26 USD BN Export of goods Money Transfers Tourism revenues FDI Total FX Inflows FX Inflows,% of GDP 40% 59% 31% 34% 29% 43% 44% 41% 46% 47% 25% 41% 45% 49% 68% 20% 5% 6% 0% 10% 8% 7% 13% 20% 34% 35% 24% 16% 7% 2% 3% 28% 28% 51% 66% 40% 38% 38% 30% 8% 11% 33% 28% 19% 28% 14% 1.0 1.0 1.8 1.7 1.7 2.0 1.4 1.4 0.6 1.3 2.2 1.9 1.6 1.7 0.18 0.27 -0.2 0.3 0.8 1.3 1.8 2.3 EU+UK Russia CIS w/o Russia China US Other countries Total FDI, US$ BLN -6.7% -6.0% -12.4% -10.3% -4.4% -5.5% -5.3% -2.6% -7.9% -3.8% 7.5% 7.8% 6.7% 8.9% 6.3% 4.6% 4.4% 2.3% 3.0% -32% -22% -12% -2% 8% 18% 28% 2018 2019 2020 2021 2022 2023 2024 2025 1Q25 1Q26 Goods, net Services, net Investment income, net Current transfers, net Current account FDI, inflows

Page 65

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY 03 2Q26 & 1H26 PERFORMANCE OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES CONTENTS ▪ Board of directors and management team ▪ Georgia Capital financial statements 65

Page 66

66 OUR ROBUST CORPORATE GOVERNANCE FRAMEWORK BOARD OF DIRECTORS COMPOSITION IRAKLI GILAURI, CHAIRMAN & CEO Experience: Formerly BGEO Group CEO; more than 20 years of experience in the banking, investment and finance. BMS in banking from CASS Business School, London; BBS from University of Limerick, Ireland MARIA CHATTI-GAUTIER INDEPENDENT NON-EXECUTIVE DIRECTOR Experience: Over 25 years of experience in private equity in prominent financial institutions. Currently Senior Advisor of Trail Management NEIL JANIN INDEPENDENT NON-EXECUTIVE DIRECTOR Experience: Formerly Chair and Non-Executive Director of BGEO Group, Non- Executive Director of GHG, Director of McKinsey & Company for over 27 years. MASSIMO GESUA’SIVE SALVADORI INDEPENDENT NON-EXECUTIVE DIRECTOR Experience: Currently an analyst at Lancaster Asset Management, formerly with McKinsey & Company for over 9 years DAVID MORRISON SENIOR INDEPENDENT NON-EXECUTIVE DIRECTOR Experience: Formerly Director at Sullivan & Cromwell with a track record of over 28 years, Founder of the Caucasus Nature Fund (CNF) 4 OUT OF 5 MEMBERS ARE INDEPENDENT

Page 67

GIORGI ALPAIDZE, DEPUTY CEO, CHIEF FINANCIAL OFFICER Formerly BGEO Group CFO. Joined BGEO as Head of Group’s Finance, Funding and Investor Relations in 2016. He has extensive international experience in banking, accounting and finance. Previously, he was a senior manager in Ernst & Young LLP’s Greater New York City’s assurance practice. Holds a BBA from the European School of Management in Georgia. US Certified Public Accountant. IRAKLI GILAURI, CHAIRMAN & CEO Irakli Gilauri formerly served as the CEO of BGEO Group from 2011 to May 2018. He joined as CFO of Bank of Georgia in 2004 and was appointed as Chairman of the Bank in September 2015, having previously served as CEO of the Bank since May 2006. Prior, he was an EBRD (European Bank for Reconstruction and Development) banker. Mr Gilauri has up to 20 years of experience in banking, investment and finance. Over the last decade, Irakli’s leadership has been instrumental in creating major players in a number of Georgian industries, including banking, healthcare, utilities and energy, real estate, insurance and wine. Holds an MSc in banking from Cass Business School and a certificate in winemaking from the University of California, Davis. GIGI GETIA, HEAD OF INVESTMENTS Gigi Getia joined BGEO Group PLC in 2017 as an Investment Officer and subsequently held senior investment roles at Georgia Capital. He later worked at Lombardi Capital, a long/short equity hedge fund and has also worked at T. Rowe Price. He holds a Master’s in Finance from London Business School and is a CFA Charterholder. MARIAM TITBERIDZE, GENERAL COUNSEL Mariam joined BGEO Group in 2017 as a Group Lawyer and was subsequently appointed Senior Corporate Lawyer at Georgia Capital, a role she held from 2018 to 2025. Prior to joining BGEO Group, she practiced law at a leading Georgian law firm. Mariam has extensive experience in M&A transactions, commercial and corporate law, private equity investments, and project financing. She holds an LL.M. (with Merit) in Transborder Commercial Law from Riga Graduate School of Law and an LL.B. from Tbilisi State University. Mariam is a member of the Georgian Bar Association. NINO VAKHVAKHISHVILI, CHIEF ECONOMIST Joined Georgia Capital in 2018. Nino is an IMF’s Short-term Expert and a visiting lecturer at the University of Georgia. Before joining the company, she spent over five years at the National Bank of Georgia. Holds a master’s degree in economics from ISET. 67 GCAP’S HIGHLY EXPERIENCED MANAGEMENT TEAM EKA DUCHIDZE, EXECUTIVE DIRECTOR Formerly served as CEO of Amber Group, a hospitality business of Georgia Capital. Previously, she was a corporate secretary and investor relations coordinator at BGEO Group. Joined Bank of Georgia as Corporate Secretary in 2005. During the past years, she has carried out a number of crucial roles, including Executive Assistant to CEO and Head of Internal Branding. Recently, Eka oversaw the development of SOLO Banking and SOLO Lifestyle at Bank of Georgia. Prior, she served for eight years at the World Bank Group of which for two years she was at the World Bank HQ in Washington DC as a Programme Assistant in the OPIC Department.

Page 68

01 GEORGIA CAPITAL AT A GLANCE 02 OUR STRATEGY 03 2Q26 & 1H26 PERFORMANCE OVERVIEW 04 PORTFOLIO OVERVIEW 05 MACROECONOMIC OVERVIEW | GEORGIA 06 APPENDICES ▪ Board of directors and management team ▪ Georgia Capital financial statements CONTENTS 68

Page 69

2026 2027 2028 2029 - 2036 Total Large portfolio companies 68.5 70.5 23.3 378.1 540.3 Retail (pharmacy) 35.9 62.1 13.9 8.9 120.8 Healthcare services 29.2 1.1 1.2 364.7 396.2 Insurance (P&C and medical) 3.4 7.3 8.2 4.5 23.3 Emerging and other portfolio companies 29.1 243.2 17.3 48.0 337.6 Total 97.6 313.7 40.6 426.1 878.0 PRIVATE PORTFOLIO COMPANIES’ DEBT MATURITY PROFILE GROSS DEBT MATURITY AS OF 30 JUNE 2026 (GEL MILLION) 69Georgia Capital PLC | 1. Gross debt of the healthcare services business comprises GEL 350 million social bonds, maturing in 2030. 2. Gross debt of emerging and other portfolio companies comprises of a US$ 80 million green bond issued by the renewable energy business, maturing in 2027 and a US$ 10 million local bond issued by the hospitality business, also maturing in 2027. 1 2

Page 70

VALUE CREATION IN PRIVATE PORTFOLIO | 2Q26 723.5 GEL MILLION TOTAL VALUE CREATION IN 2Q26 484.1 GEL MILLION 239.4 GEL MILLION LISTED PORTFOLIO PRIVATE PORTFOLIO 70 Portfolio Businesses Operating Performance Multiple Change and FX Value Creation GEL ‘000, unless otherwise noted (unaudited) (1) (2) (1)+(2) Listed portfolio 484,134 Lion Finance Group 484,134 Private portfolio 126,786 112,572 239,358 Large portfolio companies 126,528 112,587 239,115 Retail (pharmacy) 62,263 61,718 123,981 Healthcare services 42,135 24,634 66,769 Insurance 22,130 26,235 48,365 Emerging and other businesses 258 (15) 243 Total portfolio 126,786 112,572 723,492

Page 71

VALUE CREATION IN PRIVATE PORTFOLIO | 1H26 772.3 GEL MILLION TOTAL VALUE CREATION IN 1H26 455.0 GEL MILLION 317.4 GEL MILLION LISTED PORTFOLIO PRIVATE PORTFOLIO 71 Portfolio Businesses Operating Performance Multiple Change and FX Value Creation GEL ‘000, unless otherwise noted (unaudited) (1) (2) (1)+(2) Listed portfolio 454,973 Lion Finance Group 454,973 Private portfolio 279,068 38,297 317,365 Large portfolio companies 280,757 62,037 342,794 Retail (pharmacy) 129,965 46,059 176,024 Healthcare services 52,165 20,837 73,002 Insurance 98,627 (4,859) 93,768 Emerging and other businesses (1,689) (23,740) (25,429) Total portfolio 279,068 38,297 772,338

Page 72

NAV STATEMENT | 2Q26 72 GEL ‘000, unless otherwise noted (unaudited) Mar-26 1. Value creation 2a. Investment and Divestments 2b. Buyback 2c. Dividends 3. Operating expenses 4. Liquidity/ FX/Other Jun-26 Change % Listed portfolio Lion Finance Group 2,383,121 484,134 (302,212) - (27,557) - - 2,537,486 6.5% Total listed portfolio value 2,383,121 484,134 (302,212) - (27,557) - - 2,537,486 6.5% Listed portfolio value change % 20.3% -12.7% 0.0% -1.2% 0.0% 0.0% 6.5% Private portfolio companies Large portfolio companies 2,111,700 239,115 - - (18,203) - 1,541 2,334,153 10.5% Retail (pharmacy) 922,525 123,981 - - (11,926) - 737 1,035,317 12.2% Healthcare services 620,471 66,769 - - - - 436 687,676 10.8% Insurance 568,704 48,365 - - (6,277) - 368 611,160 7.5% Emerging and other companies 549,762 243 (7,922) - (973) - 557 541,667 -1.5% Total private portfolio value 2,661,462 239,358 (7,922) - (19,176) - 2,098 2,875,820 8.1% Private portfolio value change % 9.0% -0.3% 0.0% -0.7% 0.0% 0.1% 8.1% Total portfolio value (1) 5,044,583 723,492 (310,134) - (46,733) - 2,098 5,413,306 7.3% Total portfolio value change % 14.3% -6.1% 0.0% -0.9% 0.0% 0.0% 7.3% Net cash (2) 96,072 - 326,505 (70,534) 46,733 (9,699) (5,134) 383,943 NMF of which, cash and liquid funds 210,731 - 326,505 (70,534) 47,949 (9,699) (5,108) 499,844 NMF of which, loans issued 2,329 - - - - - 96 2,425 4.1% of which, accrued dividend income 19,470 - - - (1,216) - - 18,254 -6.2% of which, gross debt (136,458) - - - - - (122) (136,580) 0.1% Net other assets/(liabilities) (3) 11,418 - (16,371) 1,515 - (4,390) 4,282 (3,546) NMF of which, share-based comp. - - - - - (4,390) 4,390 - NMF Net asset value (1)+(2)+(3) 5,152,073 723,492 - (69,019) - (14,089) 1,246 5,793,703 12.5% NAV change % 14.0% 0.0% -1.3% 0.0% -0.3% 0.0% 12.5% Shares outstanding 33,278,673 - - (479,640) - - 285,579 33,084,612 -0.6% Net asset value per share, GEL 154.82 21.74 (0.00) 0.45 (0.00) (0.43) (1.45) 175.12 13.1% NAV per share, GEL change % 14.0% 0.0% 0.3% 0.0% -0.3% -0.9% 13.1%

Page 73

NAV STATEMENT | 1H26 73 GEL ‘000, unless otherwise noted (unaudited) Dec-25 1. Value creation 2a. Investment and Divestments 2b. Buyback 2c. Dividends 3. Operating expenses 4. Liquidity/ FX/Other Jun-26 Change % Listed portfolio Lion Finance Group 2,489,286 454,973 (345,021) - (61,752) - - 2,537,486 1.9% Total listed portfolio value 2,489,286 454,973 (345,021) - (61,752) - - 2,537,486 1.9% Listed portfolio value change % 18.3% -13.9% 0.0% -2.5% 0.0% 0.0% 1.9% Private portfolio companies Large portfolio companies 2,011,844 342,794 - - (23,566) - 3,081 2,334,153 16.0% Retail (pharmacy) 869,744 176,024 - - (11,926) - 1,475 1,035,317 19.0% Healthcare services 613,803 73,002 - - - - 871 687,676 12.0% Insurance 528,297 93,768 - - (11,640) - 735 611,160 15.7% Emerging and other companies 573,755 (25,429) (6,657) - (973) - 971 541,667 -5.6% Total private portfolio value 2,585,599 317,365 (6,657) - (24,539) - 4,052 2,875,820 11.2% Private portfolio value change % 12.3% -0.3% 0.0% -0.9% 0.0% 0.2% 11.2% Total portfolio value (1) 5,074,885 772,338 (351,678) - (86,291) - 4,052 5,413,306 6.7% Total portfolio value change % 15.2% -6.9% 0.0% -1.7% 0.0% 0.1% 6.7% Net cash (2) 102,909 - 368,049 (144,393) 86,291 (17,916) (10,997) 383,943 NMF of which, cash and liquid funds 219,565 - 368,049 (144,393) 88,273 (17,916) (13,734) 499,844 NMF of which, loans issued 2,236 - - - - - 189 2,425 8.5% of which, accrued dividend income 20,236 - - - (1,982) - - 18,254 -9.8% of which, gross debt (139,128) - - - - - 2,548 (136,580) -1.8% Net other assets/(liabilities) (3) 16,733 - (16,371) (653) - (9,521) 6,266 (3,546) NMF of which, share-based comp. - - - - - (9,521) 9,521 - NMF Net asset value (1)+(2)+(3) 5,194,527 772,338 - (145,046) - (27,437) (679) 5,793,703 11.5% NAV change % 14.9% 0.0% -2.8% 0.0% -0.5% 0.0% 11.5% Shares outstanding 33,582,800 - - (1,068,674) - - 570,486 33,084,612 -1.5% Net asset value per share, GEL 154.68 23.00 (0.00) 1.23 (0.00) (0.82) (2.97) 175.12 13.2% NAV per share, GEL change % 14.9% 0.0% 0.8% 0.0% -0.5% -1.9% 13.2%

Page 74

INCOME STATEMENT | 2Q26 74 GEL ‘000, unless otherwise noted (unaudited) 2Q26 2Q25 Change Dividend income 46,733 49,697 -6.0% of which, regular dividend 37,438 16,781 NMF of which, buyback dividend 9,295 32,916 -71.8% Interest income 2,734 1,847 48.0% Realised/unrealised gain on liquid funds 358 23 NMF Interest expense (2,963) (8,922) -66.8% Gross operating income 46,862 42,645 9.9% Operating expenses (14,090) (9,195) 53.2% GCAP net operating income 32,772 33,450 -2.0% Fair value changes of portfolio companies Listed portfolio 456,577 557,585 -18.1% of which, Lion Finance Group PLC 456,577 553,841 -17.6% of which, Water Utility - 3,744 NMF Private portfolio companies 220,182 63,584 NMF Large portfolio companies 220,912 74,792 NMF of which, retail (pharmacy) 112,055 32,006 NMF of which, healthcare services 66,769 20,277 NMF of which, insurance 42,088 22,509 87.0% Emerging and other businesses (730) (11,208) -93.5% Total investment return 676,759 621,169 8.9% Income before foreign exchange rate movements and non-recurring expenses 709,531 654,619 8.4% Net foreign currency (loss)/gain (5,177) 4,418 NMF Non-recurring expenses (13,627) (4,491) NMF Net income 690,727 654,546 5.5%

Page 75

INCOME STATEMENT | 1H26 75 GEL ‘000, unless otherwise noted (unaudited) 1H26 1H25 Change Dividend income 86,291 57,705 49.5% of which, regular dividend 62,568 24,789 NMF of which, buyback dividend 23,723 32,916 -27.9% Interest income 5,256 4,637 13.3% Realised/unrealised gain on liquid funds 85 73 16.4% Interest expense (5,912) (18,026) -67.2% Gross operating income 85,720 44,389 93.1% Operating expenses (27,437) (18,979) 44.6% GCAP net operating income 58,283 25,410 NMF Fair value changes of portfolio companies Listed portfolio 393,221 805,534 -51.2% of which, Lion Finance Group PLC 393,221 801,790 -51.0% of which, Water Utility - 3,744 NMF Private portfolio companies 292,826 151,121 93.8% Large portfolio companies 319,228 203,310 57.0% of which, retail (pharmacy) 164,098 98,325 66.9% of which, healthcare services 73,002 69,468 5.1% of which, insurance 82,128 35,517 NMF Emerging and other businesses (26,402) (52,189) -49.4% Total investment return 686,047 956,655 -28.3% Income before foreign exchange rate movements and non-recurring expenses 744,330 982,065 -24.2% Net foreign currency (loss)/gain (8,678) 11,431 NMF Non-recurring expenses (15,006) (4,749) NMF Net income 720,646 988,747 -27.1%

Page 76

Page 77

FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements, including, but not limited to, statements concerning expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, competitive strengths and weaknesses, plans or goals relating to financial position and future operations and development. Although Georgia Capital PLC believes that the expectations and opinions reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations and opinions will prove to have been correct. By their nature, these forward-looking statements are subject to a number of known and unknown risks, uncertainties and contingencies, and actual results and events could differ materially from those currently being anticipated as reflected in such statements. Important factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements, certain of which are beyond our control, include, among other things: regional instability; currency fluctuations and risk, including depreciation of the Georgian Lari, and macroeconomic risk, regulatory risk across a wide range of industries; investment risk; liquidity risk; portfolio company strategic and execution risks and other key factors that could adversely affect our business and financial performance, which are contained elsewhere in this presentation and in our past and future filings and reports and also the 'Principal Risks and Uncertainties' included in the 1H26 Results Announcement and in Georgia Capital PLC’s Annual Report and Accounts 2025. No part of this document constitutes, or shall be taken to constitute, an invitation or inducement to invest in Georgia Capital PLC or any other entity and must not be relied upon in any way in connection with any investment decision. Georgia Capital PLC and other entities undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required. Nothing in this document should be construed as a profit forecast. 77

Page 78

COMPANY INFORMATION Georgia Capital PLC Registered Address 19th Floor 51 Lime Street London, EC3M 7DQ United Kingdom www.georgiacapital.ge Registered under number 10852406 in England and Wales Stock Listing London Stock Exchange PLC’s Main Market for listed securities Ticker: “CGEO.LN” Contact Information Georgia Capital PLC Investor Relations Telephone: +44 (0) 203 178 4034; +995 322 000000 E-mail: ir@gcap.ge Auditors PricewaterhouseCoopers LLP (“PwC”) 7 More London Riverside, London SE1 2RT, United Kingdom Registrar Computershare Investor Services PLC The Pavilions Bridgwater Road Bristol BS13 8AE United Kingdom Please note that Investor Centre is a free, secure online service run by our Registrar, Computershare, giving you convenient access to information on your shareholdings. Investor Centre Web Address - www.investorcentre.co.uk. Investor Centre Shareholder Helpline - +44 (0) 370 873 5866 Share price information Shareholders can access both the latest and historical prices via the website www.georgiacapital.ge

Slides